MetLife Investment Management’s Medidata Solutions, Inc. MDSO Stock Holding History

MetLife Investment Management’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-36,213	Closed	-$3.31M	–	2378
2019 Q3	$3.31M	Sell	36,213 -25,337	-41%	-$2.31M	0.04%	547
2019 Q2	$5.57M	Sell	61,550 -990	-2%	-$86.9K	0.06%	303
2019 Q1	$4.58M	Buy	62,540 +649	+1%	+$46.8K	0.05%	375
2018 Q4	$4.17M	Buy	61,891 +774	+1%	+$54.6K	0.05%	357
2018 Q3	$4.48M	Sell	61,117 -2,236	-4%	-$179K	0.05%	411
2018 Q2	$5.1M	Buy	63,353 +256	+0.4%	+$19.2K	0.06%	299
2018 Q1	$3.96M	Sell	63,097 -24	-0%	-$1.6K	0.05%	441
2017 Q4	$4M	Buy	+63,121	New	+$4.5M	0.05%	468

Other funds holding MDSO

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

MetLife Investment Management's MDSO Position: Q4 2019 in Review

MetLife Investment Management sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 36,213 shares — an estimated $3.31M sold.

MetLife Investment Management first reported a position in MDSO in Q4 2017 and held it in 8 quarters. The position peaked at $5.57M in Q2 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

MetLife Investment Management reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
MetLife Investment Management sold 36,213 Medidata Solutions, Inc. shares in Q4 2019, an estimated $3.31M.
MetLife Investment Management first reported a position in Medidata Solutions, Inc. in Q4 2017 and held it in 8 quarters.
MetLife Investment Management's Medidata Solutions, Inc. position peaked at $5.57M in Q2 2019.
1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.